ARTV
Artiva Biotherapeutics, Inc.
-0.16 (-1.92%)8.44USD177K成交股數412M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 251K | – | 26.7M | 3.5M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 21.9M | 19.3M | 17.0M | 17.6M | 17.9M | 17.1M | 13.5M | 12.3M | 11.2M | – | 13.1M | 11.3M |
| 銷售管理費用 | 5.0M | 5.1M | 4.9M | 5.3M | 4.9M | 5.1M | 4.8M | 3.9M | 3.6M | – | 2.8M | 4.1M |
| 營業利益 | −26.9M+18% | −24.4M+10% | −21.9M+20% | −22.9M+41% | −22.8M+57% | −22.2M | −18.3M-270% | −16.2M+37% | −14.5M | – | 10.8M | −11.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | -5,773.7% | – | 40.6% | -338.1% |
| 稅後淨利 | −25.0M+18% | −23.5M+16% | −20.8M+19% | −21.5M+21% | −21.3M+52% | −20.3M+69% | −17.5M-255% | −17.8M+58% | −14.0M | −12.0M | 11.3M | −11.3M |
| 淨利率 | – | – | – | – | – | – | – | – | -5,562.9% | – | 42.3% | -322.7% |
| 稀釋 EPS | -0.63-28% | -0.95+14% | -0.85-8% | -0.88-96% | -0.87-95% | -0.83 | -0.92-157% | -22.00+56% | -17.24 | – | 1.62 | -14.09 |
| 稀釋股數 | 39.4M | 24.7M | 24.4M | 24.5M | 24.4M | 24.3M | 18.9M | 811K | 810K | 803K | 7.0M | 801K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 301M | 21.0M | 26.7M | 25.5M | 28.5M | 30.4M | 55.9M | 34.2M | 48.2M | 53.5M | 65.9M | 53.7M |
| 應收帳款 | – | – | – | – | – | – | 569K | 569K | – | 1.0M | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 369M | 106M | 131M | 149M | 169M | 191M | 226M | 75.9M | – | 105M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 21.1M | 18.1M | 21.0M | 19.6M | 20.4M | 22.5M | 24.6M | 50.6M | – | 50.7M | – | – |
| 股東權益 | 348M | 87.8M | 110M | 129M | 149M | 169M | 201M | −191M | −175M | −162M | −151M | −164M |
| 負債比 | 5.7% | 17.1% | 16.0% | 13.2% | 12.0% | 11.8% | 10.9% | 66.7% | – | 48.2% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −21.0M+6% | – | – | – | −19.8M | – | – | −15.1M | – | – | – |
| 資本支出 | – | 242K | – | – | – | 511K | – | – | 18K | – | – | – |
| 自由現金流 | – | −21.2M+4% | – | – | – | −20.4M | – | – | −15.1M | – | – | – |
| 折舊攤銷 | – | 666K | – | – | – | 628K | – | – | 587K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -6,017.5% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | -100.0% | −83.9M | –% | -3.43 | −79.3M |
| FY2024 | 251K | -99.2% | −65.4M | -26,045.0% | -5.81 | −55.7M |
| FY2023 | 32.9M | – | −28.7M | -87.2% | -35.78 | −50.7M |